The 2024 Nobel Prize in Physiology or Medicine has been bestowed upon Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNA and its pivotal role in post-transcriptional gene regulation.
The Nobel Assembly at the Karolinska Institute in Sweden announced on October 7 that the prize honors the 'discovery of a fundamental principle governing how gene activity is regulated.' Ambros, from the University of Massachusetts Chan Medical School in Worcester, and Ruvkun, from Harvard Medical School, will share the prize, which amounts to 11 million Swedish kroner, approximately $1 million.
This story is still unfolding and will be updated later today.